{"id":66901,"date":"2021-09-28T16:34:53","date_gmt":"2021-09-28T14:34:53","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/"},"modified":"2025-10-13T15:32:05","modified_gmt":"2025-10-13T13:32:05","slug":"el-avance-en-la-madurez-de-las-startups-las-fases-clinicas","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/","title":{"rendered":"El avance en la madurez de las startups: las fases cl\u00ednicas"},"content":{"rendered":"<p><strong>Las startups con las que colabora la consultora Genesis Biomed, con sede en el Parque Cient\u00edfico de Barcelona (PCB), avanzan en su madurez, como Peptomyc, aptaTargets y Oxolife, que se acercan a un escenario de salida con el inicio y desarrollo de las fases cl\u00ednicas.<\/strong><\/p>\n<p>El inicio y avance de fases cl\u00ednicas son un momento importante en el desarrollo de un medicamento. Si los resultados son favorables, aumentan las probabilidades de la llegada del f\u00e1rmaco al mercado, provocando una valorizaci\u00f3n del proyecto que permitir\u00e1 escenarios de salida para los inversores.<\/p>\n<p>Por esta raz\u00f3n, Genesis Biomed, que apuesta firmemente por el emprendimiento y el desarrollo empresarial del sector biom\u00e9dico, sigue con especial inter\u00e9s el avance hacia la madurez de las startups con las cuales colabora o ha colaborado, algunas de las cuales, como Peptomyc,\u00a0 aptaTargets, y Oxolife, ubicada en el Parque, han conseguido llevar sus proyectos a la fase cl\u00ednica.<\/p>\n<p><strong>\u00bb <a href=\"https:\/\/genesis-biomed.com\/es\/el-avance-en-la-madurez-de-las-start-ups-las-fases-clinicas\" target=\"_blank\" rel=\"noopener\">Enlace al post de\u00a0Genesis\u00a0Biomed\u00a0[+]<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Las startups con las que colabora la consultora Genesis Biomed, con sede en el Parque Cient\u00edfico de Barcelona (PCB), avanzan en su madurez, como Peptomyc, aptaTargets y Oxolife, que se&#8230;<\/p>\n","protected":false},"author":14,"featured_media":66898,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-66901","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El avance en la madurez de las startups: las fases cl\u00ednicas - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El avance en la madurez de las startups: las fases cl\u00ednicas - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Las startups con las que colabora la consultora Genesis Biomed, con sede en el Parque Cient\u00edfico de Barcelona (PCB), avanzan en su madurez, como Peptomyc, aptaTargets y Oxolife, que se...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-28T14:34:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:32:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/09\/maturity_start_ups_genesis_biomed.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"El avance en la madurez de las startups: las fases cl\u00ednicas\",\"datePublished\":\"2021-09-28T14:34:53+00:00\",\"dateModified\":\"2025-10-13T13:32:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/\"},\"wordCount\":176,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/maturity_start_ups_genesis_biomed.jpg\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/\",\"name\":\"El avance en la madurez de las startups: las fases cl\u00ednicas - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/maturity_start_ups_genesis_biomed.jpg\",\"datePublished\":\"2021-09-28T14:34:53+00:00\",\"dateModified\":\"2025-10-13T13:32:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/maturity_start_ups_genesis_biomed.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/maturity_start_ups_genesis_biomed.jpg\",\"width\":900,\"height\":333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El avance en la madurez de las startups: las fases cl\u00ednicas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El avance en la madurez de las startups: las fases cl\u00ednicas - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/","og_locale":"es_ES","og_type":"article","og_title":"El avance en la madurez de las startups: las fases cl\u00ednicas - Parc Cient\u00edfic de Barcelona","og_description":"Las startups con las que colabora la consultora Genesis Biomed, con sede en el Parque Cient\u00edfico de Barcelona (PCB), avanzan en su madurez, como Peptomyc, aptaTargets y Oxolife, que se...","og_url":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2021-09-28T14:34:53+00:00","article_modified_time":"2025-10-13T13:32:05+00:00","og_image":[{"width":900,"height":333,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/09\/maturity_start_ups_genesis_biomed.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"El avance en la madurez de las startups: las fases cl\u00ednicas","datePublished":"2021-09-28T14:34:53+00:00","dateModified":"2025-10-13T13:32:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/"},"wordCount":176,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/09\/maturity_start_ups_genesis_biomed.jpg","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/","url":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/","name":"El avance en la madurez de las startups: las fases cl\u00ednicas - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/09\/maturity_start_ups_genesis_biomed.jpg","datePublished":"2021-09-28T14:34:53+00:00","dateModified":"2025-10-13T13:32:05+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/09\/maturity_start_ups_genesis_biomed.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/09\/maturity_start_ups_genesis_biomed.jpg","width":900,"height":333},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/el-avance-en-la-madurez-de-las-startups-las-fases-clinicas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"El avance en la madurez de las startups: las fases cl\u00ednicas"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/66901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=66901"}],"version-history":[{"count":3,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/66901\/revisions"}],"predecessor-version":[{"id":66914,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/66901\/revisions\/66914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/66898"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=66901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=66901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=66901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}